Science Announces Top Ten Research Advances Of 1998

December 18, 1998

Washington D.C. - In the 18 December 1998 issue, the editors of Science will announce their picks for the year's ten most important advances in science research. Heading the list is the accelerating universe, the discovery that galaxies of the cosmos are flying apart at ever faster speeds. Each year Science selects those advances from the past twelve months that have profoundly changed the practice or interpretation of science or its implications for society.

In the top research advance of 1998, the accelerating universe, two international teams of astronomers provided a glimpse into the destiny of the universe when they looked at distant stars and found that they were rushing apart at an accelerating rate. Scientists discovered decades ago that the universe has been expanding since the Big Bang. But whether the gravitational pull between galaxies could slow-and ultimately reverse-that expansion has been unknown. This year's discovery showed that the expansion of the universe is in fact speeding up. This implies that gravity is no match for the force that is pushing the universe outwards in all directions and that the expansion may continue, perhaps indefinitely.

The force propelling the expansion is still a mystery, but a leading candidate is a mysterious and pervasive energy in the universe called the cosmological constant - which Albert Einstein conceived of but later deemed his "biggest blunder." This year's top research advance may validate Einstein's first instincts; the energy of the cosmological constant could be providing the repulsive force necessary to propel the increasingly rapid expansion of the universe.

As the world's leading peer-reviewed general science journal, Science is uniquely suited to draw from a diverse array of scientific fields in order to compile the most authoritative list of the year's scientific accomplishments.

The other advances are as follows. Except for the first runner up, all other runners up are in no particular order:

This year's annual "Breakthrough of the Year" section is the tenth since Science inaugurated the feature. The ten research advances were chosen by the editors, led by Editor-in-Chief Floyd E. Bloom, M.D. of Scripps Research Institute in La Jolla, CA. Bloom writes about the "Breakthrough of the Year" report in the 18 December issue's editorial, which is available upon request.

A draft of the "Breakthrough of the Year" section is available, under embargo, from the AAAS News & Information Office. The editorial by Dr. Bloom will be available Friday, 11 December. The cover of the 18 December issue of Science relates to the "Breakthrough of the Year" section and will be available Friday, 11 December.

For more information about the "Breakthrough of the Year" section, please contact Elizabeth Culotta, Contributing News Editor, at 330-678-7700 (phone) or (email).

For more information regarding the top research advance of 1998, the Accelerating Universe, please contact: Saul Perlmutter, Team Leader, Supernova Cosmology Project, Lawrence Berkeley National Laboratory at 510-486-5203 (work phone) or 510-841-7285 (home phone), or (email); and Brian Schmidt, team leader, High-z Supernova Search Team, Mt. Stromlo and Siding Spring Observatory, Australia, (EST+16 hours), at 61-2-6279-8042 (phone), 61-2-6249-0233 (fax), or More contact information, including contacts in Europe and Latin America, is available upon request from the AAAS News & Information office.

For copies of the "Breakthrough of the Year" section or the editorial, please email, call 202-326-6440 or fax the form below to 202-789-0455. For cover art, please contact Heather Singmaster at 202-326-6414 (phone), or (email).






American Association for the Advancement of Science

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to